Vital Signs Monitoring Devices Market Report 2026

Vital Signs Monitoring Devices Market Overview

• Vital Signs Monitoring Devices market size has reached to $11.07 billion in 2025 • Expected to grow to $18.68 billion in 2030 at a compound annual growth rate (CAGR) of 11% • Growth Driver: Rising Cardiovascular Disease Cases Driving Growth Of The Market Due To Increasing Need For Early Detection And Management • Market Trend: Advancements In Vital Sign Monitoring Technology With Integrated Early Warning Scoring Systems • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vital Signs Monitoring Devices Market?

Vital signs monitoring devices are medical tools designed to continuously or periodically measure and record key physiological parameters that reflect the body’s essential functions. These devices play a fundamental role in healthcare by enabling the observation of physiological trends and supporting timely clinical decisions. The main products of vital signs monitoring devices include pulse oximeters, blood pressure monitors, temperature monitoring devices, and glucose monitoring devices. Pulse oximeters are small devices that measure the level of oxygen in a person's blood by attaching to a finger or earlobe. It can be both standalone and portable and is used for various end uses, including hospitals, physician’s offices, home healthcare, ambulatory centers, emergency care centers, and others.

What Is The Vital Signs Monitoring Devices Market Growth Forecast?

The vital signs monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $18.68 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to growth in home healthcare services, technological advancements in sensor technologies, rising geriatric population, increasing adoption of remote patient monitoring, demand for real-time clinical decision support. Major trends in the forecast period include growing adoption of continuous and remote vital signs monitoring, rising demand for portable and home healthcare monitoring devices, increased focus on early detection and preventive care, expansion of multi-parameter monitoring solutions, improved accuracy and reliability of non-invasive monitoring devices.

Global Vital Signs Monitoring Devices Market Segmentation

1) By Product: Pulse Oximeters, Blood Pressure Monitors, Temperature Monitoring Devices, Glucose Monitoring Devices 2) By Mount Type: Standalone, Portable 3) By End-Use: Hospitals, Physician’s Office, Home Healthcare, Ambulatory Centers, Emergency Care Centers, Other End-Uses Subsegments: 1) By Pulse Oximeters: Fingertip Pulse Oximeters, Handheld Pulse Oximeters, Tabletop Or Benchtop Pulse Oximeters, Wrist-Worn Pulse Oximeters, Pediatric Pulse Oximeters 2) By Blood Pressure Monitors: Automated Or Digital Blood Pressure Monitors, Manual Blood Pressure Monitors, Ambulatory Blood Pressure Monitors, Wrist Blood Pressure Monitors, Upper Arm Blood Pressure Monitors 3) By Temperature Monitoring Devices: Digital Thermometers, Infrared Thermometers, Non-Contact Clinical Thermometers, Wearable Continuous Temperature Monitoring Devices, Smart Thermometers 4) By Glucose Monitoring Devices: Self-Monitoring Blood Glucose (SMBG) Devices, Continuous Glucose Monitoring (CGM) Systems

What Is The Driver Of The Vital Signs Monitoring Devices Market?

The increasing prevalence of cardiovascular diseases is anticipated to fuel the growth of the vital signs monitoring devices market in the coming years. Cardiovascular diseases are a group of disorders affecting the heart and blood vessels, often leading to conditions such as heart attacks, strokes, and other circulatory system complications. Cardiovascular diseases are rising due to increasing rates of obesity, which elevate the risk of hypertension, diabetes, and high cholesterol, all of which significantly contribute to heart-related complications. Vital signs monitoring devices are critical tools in managing, diagnosing, and preventing cardiovascular diseases (CVDs). These devices help detect early warning signs, monitor disease progression, and guide treatment decisions. For instance, in October 2024, according to the US Centers for Disease Control and Prevention (CDC), a US-based government public health agency, 919,032 people in the US died from cardiovascular disease in 2023, representing approximately one in every three deaths nationwide. Therefore, the increasing prevalence of cardiovascular diseases will drive the growth of the vital signs monitoring devices industry.

Key Players In The Global Vital Signs Monitoring Devices Market

Major companies operating in the vital signs monitoring devices market are Medtronic Plc, Koninklijke Philips NV, GE Healthcare Technologies Inc, Omron Healthcare, Mindray Ltd, Masimo Corp, Nihon Kohden Corp, Lepu Medical Technology Co Ltd, Contec Medical Systems Co Ltd, A And D Company Ltd, Spacelabs Healthcare Inc, Schiller AG, Edan Instruments Inc, Shenzhen Comen Medical Instruments Co Ltd, Nonin Medical Inc, Recorders And Medicare Systems P Ltd, BPL Medical Technologies, SunTech Medical Inc, Rossmax International Ltd, Allengers Medical Systems Ltd, Huntleigh Healthcare LLC, BioBeat Technologies, Ababil Healthcare

Global Vital Signs Monitoring Devices Market Trends and Insights

Major companies operating in the vital signs monitoring devices market are focusing on developing advanced solutions, such as early warning scoring tools with integrated monitoring devices, to reduce the risk of human error. Early warning scoring tools integrated with monitoring devices are systems that continuously assess patient vital signs to detect early signs of clinical deterioration and prompt, timely medical intervention. For instance, in July 2024, Huntleigh, a US-based medical equipment manufacturer, launched the SC500 Series vital signs monitor. It offers high-performance monitoring that supports spot checks and medium- to long-term observations, filling the gap between entry-level and multi-parameter monitors. It features integrated early warning scoring tools and three-level alarms, making it well-suited for long COVID-19 monitoring. With an 8-inch color display and battery or mains operation, the device provides comprehensive vital signs monitoring for adult, pediatric, and neonatal patients, including non-invasive blood pressure, pulse rate, pulse oximetry, 3-lead ECG, and an optional wireless tympanic temperature sensor. Additionally, the SC500 supports streamlined workflows through its standard connectivity options and compatibility with Smartsigns Central View monitoring software for centralized data management.

What Are Latest Mergers And Acquisitions In The Vital Signs Monitoring Devices Market?

In September 2024, Becton, Dickinson and Company (BD), a US-based medical technology company, acquired the Critical Care product group of Edwards Lifesciences Corporation for USD 4.2 billion. Through this acquisition, Becton, Dickinson and Company gains access to advanced hemodynamic monitoring technologies, artificial intelligence (AI)-enabled clinical decision-support tools and a portfolio of minimally invasive and noninvasive monitoring systems, thereby expanding its smart connected care capabilities while improving its reach and integration across infusion and monitoring platforms. Edwards Lifesciences Corporation is a US-based manufacturing company that specializes in providing advanced patient monitoring devices and sensors and is known for its leadership in hemodynamic monitoring technologies used in intensive care and surgical settings.

Regional Outlook

North America was the largest region in the vital signs monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Vital Signs Monitoring Devices Market?

The vital signs monitoring devices market consists of sales of respiratory rate monitors, wearable health trackers, multi-parameter patient monitors, and neonatal vital signs monitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.